REACTIONS FOLLOWING IMMUNIZATION WITH JAPANESE ENCEPHALITIS VIRUS VACCINE
接种日本脑炎病毒疫苗后的反应
基本信息
- 批准号:3792543
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Japanese encephalitis virus is the causative agent of an acute
inflammatory illness of the central nervous system found throughout
eastern Asia. A formalin inactivated, mouse-brain derived Japanese
encephalitis virus vaccine has been developed. A report of severe
urticarial reactions associated with immunization with Japanese
encephalitis virus vaccine was published in 1991 in The Lancet. The
rate of severe side-effects was reported to be 0.04%. The description
of the adverse reactions was similar to allergic reactions seen when
booster doses of rabies vaccine were given. The Centers for Disease
Control were invited to participate in an investigation of the reactors.
A case-control study found that persons developing these reactions after
JE vaccination were more likely to have had a past history of urticaria
(after hymenoptera envenomation, drugs, physical or other provocations
or of idiopathic cause). Sixteen reactors were skin tested with the
vaccine causing the allergic reaction at least 5 weeks after the
reaction. None of the reactors showed skin test positivity. Acute and
convalescent sera were drawn for testing for IgE levels and reactivity
with the vaccine. These tests are still in progress. The mechanism and
cause of these reactions is still unknown. The vaccine labeling will
include adequate warnings to inform physicians and recipients of the
vaccine about the allergic reactions.
日本脑炎病毒是一种急性脑炎的病原体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
L A SAWYER其他文献
L A SAWYER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('L A SAWYER', 18)}}的其他基金
NONRESPONDERS TO HUMAN DIPLOID CELL RABIES VACCINE, INTRADERMAL
对人二倍体细胞狂犬病皮内疫苗无反应者
- 批准号:
3804819 - 财政年份:
- 资助金额:
-- - 项目类别:
REACTIONS FOLLOWING IMMUNIZATION WITH JAPANESE ENCEPHALITIS VIRUS VACCINE
接种日本脑炎病毒疫苗后的反应
- 批准号:
3804818 - 财政年份:
- 资助金额:
-- - 项目类别:
VARYING REACTIVITIES OF MONOCLONAL ANTIBODIES WITH THE SAME POLIO VACCINE
相同脊髓灰质炎疫苗的单克隆抗体的不同反应性
- 批准号:
3811260 - 财政年份:
- 资助金额:
-- - 项目类别:
WHO COLLABORATIVE STUDY OF INACTIVATED POLIOVIRUS VACCINE
世界卫生组织灭活脊髓灰质炎病毒疫苗合作研究
- 批准号:
3792544 - 财政年份:
- 资助金额:
-- - 项目类别:
STANDARDIZATION OF POTENCY TEST METHODS FOR IPV-WHO STUDY
IPV-WHO 研究效力测试方法的标准化
- 批准号:
3770312 - 财政年份:
- 资助金额:
-- - 项目类别:
IMMUNOGENICITY OF CURRENT MEASLES VACCINE IN HIV-INFECTED CHILDREN
当前麻疹疫苗对艾滋病毒感染儿童的免疫原性
- 批准号:
3770314 - 财政年份:
- 资助金额:
-- - 项目类别:
VARYING REACTIVITIES OF MONOCLONAL ANTIBODIES WITH THE SAME POLIO VACCINE
相同脊髓灰质炎疫苗的单克隆抗体的不同反应性
- 批准号:
3804814 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Evaluation of Transmission Low-frequency Raman Spectroscopy for Application to Quality Assurance of Continuous Manufactured Solid Dosage Forms
透射低频拉曼光谱在连续生产固体剂型质量保证中的应用评价
- 批准号:
23K06071 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: microRNA-mediated regulation of dosage sensitive genes involved in morphogenesis
职业:微小RNA介导的形态发生剂量敏感基因的调节
- 批准号:
2238425 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
Use of Additives in Oral Solid Dosage Forms to Inhibit Nitrosamine Formation
在口服固体剂型中使用添加剂抑制亚硝胺形成
- 批准号:
2896874 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
一项 2 期、随机、双盲、4 组、多中心研究,旨在证明处方药局部剂量制剂治疗光化性角化病的有效性和安全性
- 批准号:
10820810 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Estimation of optimal dosage of opioid based on vascular stiffness value
基于血管硬度值估算阿片类药物最佳剂量
- 批准号:
23K15598 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mapping and prediction of quantitative transcription factor dosage effects to understand variation in craniofacial morphology and disease
定量转录因子剂量效应的绘图和预测,以了解颅面形态和疾病的变化
- 批准号:
10641572 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Creation of trait diversity through gene dosage effects in allopolyploid wheat
通过异源多倍体小麦基因剂量效应创造性状多样性
- 批准号:
22KJ1943 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
Optimizing dosage and CTA-Enabling Pre-clinical Gene Therapy Studies for Creatine Transporter Deficiency
优化剂量和支持 CTA 的肌酸转运蛋白缺乏症临床前基因治疗研究
- 批准号:
491901 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72
社会是小企业关注 NCGC72 的剂型开发、生产和稳定性研究
- 批准号:
10953952 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Modulating Exercise Dosage to Improve Concussion Rehabilitation: A Randomized Clinical Trial
调节运动量以改善脑震荡康复:一项随机临床试验
- 批准号:
10412780 - 财政年份:2022
- 资助金额:
-- - 项目类别:














{{item.name}}会员




